{"id":"https://openalex.org/W1991477515","doi":"https://doi.org/10.1007/bf00427122","title":"Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia","display_name":"Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia","publication_year":1979,"publication_date":"1979-01-01","ids":{"openalex":"https://openalex.org/W1991477515","doi":"https://doi.org/10.1007/bf00427122","mag":"1991477515","pmid":"https://pubmed.ncbi.nlm.nih.gov/111273"},"language":"en","primary_location":{"id":"doi:10.1007/bf00427122","doi":"https://doi.org/10.1007/bf00427122","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00427122","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037459343","display_name":"Anne Vibeke Christensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"A. V. Christensen","raw_affiliation_strings":["Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark","Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]},{"raw_affiliation_string":"Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109269271","display_name":"I. M\ufffdller Nielsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"I. M\ufffdller Nielsen","raw_affiliation_strings":["Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark","Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]},{"raw_affiliation_string":"Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I133593841"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":2.6593,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.90171699,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"62","issue":"2","first_page":"111","last_page":"116"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-receptor-supersensitivity","display_name":"dopamine receptor supersensitivity","score":0.8040000200271606},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8119999766349792},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.8870000243186951},{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.925000011920929},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9850000143051147},{"id":"https://openalex.org/keywords/deanol","display_name":"deanol","score":0.6800000071525574},{"id":"https://openalex.org/keywords/cholinergic-agents","display_name":"cholinergic drugs","score":0.6650000214576721},{"id":"https://openalex.org/keywords/anticholinergic-drugs","display_name":"anticholinergic agents","score":0.9330000281333923},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonists","display_name":"dopamine antagonists","score":0.7649999856948853},{"id":"https://openalex.org/keywords/gaba-receptor-agonists","display_name":"GABA agonists","score":0.8270000219345093},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9449999928474426},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9520000219345093},{"id":"https://openalex.org/keywords/muscimol","display_name":"muscimol","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cis-flupenthixol","display_name":"cis-flupenthixol","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.71092689037323},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.684977114200592},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6458238959312439},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.6186949610710144},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5856677889823914},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.5534100532531738},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.5512481927871704},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5381603240966797},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.5212957859039307},{"id":"https://openalex.org/C2777095659","wikidata":"https://www.wikidata.org/wiki/Q424446","display_name":"Lisuride","level":5,"score":0.45282846689224243},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.44918689131736755},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.4454600512981415},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.4340885281562805},{"id":"https://openalex.org/C2910745098","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic agents","level":3,"score":0.4108915627002716},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.41020819544792175},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.405131995677948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34486499428749084},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34352582693099976},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.060221731662750244},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.05881839990615845},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.05779200792312622},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.04840958118438721},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005475","descriptor_name":"Flupenthixol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009118","descriptor_name":"Muscimol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010276","descriptor_name":"Parasympatholytics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010277","descriptor_name":"Parasympathomimetics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00427122","doi":"https://doi.org/10.1007/bf00427122","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00427122","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:111273","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/111273","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1577439504","https://openalex.org/W1964605030","https://openalex.org/W1969168387","https://openalex.org/W1973316601","https://openalex.org/W1975216040","https://openalex.org/W1994426412","https://openalex.org/W2004727273","https://openalex.org/W2004867172","https://openalex.org/W2005232235","https://openalex.org/W2010915845","https://openalex.org/W2017472691","https://openalex.org/W2018443174","https://openalex.org/W2018507547","https://openalex.org/W2020824816","https://openalex.org/W2025081012","https://openalex.org/W2026473192","https://openalex.org/W2026493925","https://openalex.org/W2030505318","https://openalex.org/W2033318852","https://openalex.org/W2049544121","https://openalex.org/W2059680569","https://openalex.org/W2070579067","https://openalex.org/W2072714025","https://openalex.org/W2072740414","https://openalex.org/W2079334747","https://openalex.org/W2080680105","https://openalex.org/W2090970677","https://openalex.org/W2096211858","https://openalex.org/W2138826416","https://openalex.org/W2313395536","https://openalex.org/W2330111997","https://openalex.org/W2335913651","https://openalex.org/W2342953526","https://openalex.org/W2410144598","https://openalex.org/W2414521257","https://openalex.org/W2415813254","https://openalex.org/W2436132209","https://openalex.org/W2461846724","https://openalex.org/W2465896322","https://openalex.org/W2490506940","https://openalex.org/W2502085694","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2025081012","https://openalex.org/W1972190053","https://openalex.org/W2406978258","https://openalex.org/W2046236537","https://openalex.org/W1980985991","https://openalex.org/W1503976483","https://openalex.org/W2049669747","https://openalex.org/W2086370947","https://openalex.org/W2416070415","https://openalex.org/W2070761743"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}